Top Story

Early PEP effective against trichinellosis

March 26, 2015

Early treatment with mebendazole within the first 6 days of Trichinella exposure prevented the onset of clinical trichinellosis, according to recent findings.

In a prospective cohort study, researchers evaluated 101 people in Germany exposed to wild boar meat products contaminated with Trichinella spiralis. The tainted meat, discovered through routine molecular typing at the Federal Institute for Risk Assessment, had entered the food chain in March 2013. Eight kilograms of the muscle tissue of the infected boar had produced 1,050 cured raw sausages intended for raw consumption. An additional 30 kg to 35 kg were sold as fresh meat to be cooked. Those who reported eating the affected meat were interviewed about their exposure, symptoms and treatment. Seventy-one of those who completed the questionnaire also underwent Trichinella-specific laboratory diagnostic tests.

In the Journals

M. pneumoniae causes respiratory illness outbreak in care facility

March 26, 2015
An outbreak of respiratory illness at a long-term care facility in Nebraska was linked to Mycoplasma pneumoniae. During the outbreak, 55 patients experienced…

AGA gives additional suggestions to prevent duodenoscope infections

March 26, 2015
The American Gastroenterological Association has issued additional practice recommendations for preventing infections associated with endoscopic retrograde…

Botswana-UPenn partnership, Microsoft to launch telemedicine service in Botswana

March 26, 2015
The Botswana-UPenn Partnership, along with Microsoft, the Botswana Innovation Hub, and others are planning to launch the first telemedicine service in Africa…

Report highlights need for continued US support for global health

March 26, 2015
In its annual policy report, the Global Health Technologies Coalition highlighted the need for U.S. policymakers to continue to support global health research and…
More News Headlines »
CME
HBV

Critical Issues in HBV
HBV Management in Complex Populations: Volume 1, Number 2

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video
thumbnail for video 4129869191001

Video: NIAID Ebola vaccine well tolerated, immunogenic

March 23, 2015
WILMINGTON, Del. — Julie Ledgerwood, DO, of the National Institute of Allergy and Infectious Diseases' Vaccine…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
morganatic-roan